Linkedin Share

Dozens of Lawsuits Filed Alleging INEXCUSABLE Collusion Between Drug Companies

Linkedin Share

For many Americans, the healthcare industry has surpassed even Big Oil as perhaps the most vile and conniving crew on Capitol Hill.

And it wasn’t just Obamacare that sent the US citizenry spiraling into anger, although that racket was pretty slick in and of itself; forcing the taxpayers to buy into a private industry who can easily manage market value by coordinating price points.

No, the Big Pharmaceutical barons are truly the harbingers of health doom these days, constantly pressuring doctors and hospitals to prescribe more of their products to, in turn, reap the profits.

As if Americans weren’t unhappy enough with this setup, we now have evidence of price-fixing within the generic drug market.

Executives at more than a dozen generic-drug companies had a form of shorthand to describe how they conducted business, insider lingo worked out over steak dinners, cocktail receptions and rounds of golf.

Massive Migrant Caravan Marches Toward US with LGBT Flags Flying as Mexican President Snubs Biden at Summit

The “sandbox,” according to investigators, was the market for generic prescription drugs, where everyone was expected to play nice.

“Fair share” described dividing up the sales pie to ensure that each company reaped continued profits. “Trashing the market” was used when a competitor ignored these unwritten rules and sold drugs for less than agreed-upon prices.

The terminology reflected more than just the clubbiness of a powerful industry, according to authorities and several lawsuits. Officials from multiple states say these practices were central to illegal price-fixing schemes of massive proportion.

And the angry villagers marching toward the proverbial prescription mansion are gaining steam.

What started as an antitrust lawsuit brought by states over just two drugs in 2016 has exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs, Joseph Nielsen, an assistant attorney general and antitrust investigator in Connecticut who has been a leading force in the probe, said in an interview. His comments in an interview with The Washington Post represent the first public disclosure of the dramatically expanded scale of the investigation.

The unfolding case is rattling an industry that is portrayed in Washington as the white knight of American health care.

“This is most likely the largest cartel in the history of the United States,” Nielsen said. He cited the volume of drugs in the schemes, that they took place on American soil and the “total number of companies involved, and individuals.”

Side effects of the case may include nausea, headaches, and anxiety for those within the pharmaceutical industry.

Submit a Correction →

, , , ,
Linkedin Share
About the Author:
As a lifelong advocate for the dream promised us in the Constitution, Andrew West has spent his years authoring lush prose editorial dirges regarding America's fall from grace and her path back to prosperity. When West isn't railing against the offensive whims of the mainstream media or the ideological cruelty that is so rampant in the US, he spends his time seeking adventurous new food and fermented beverages, with the occasional round of golf peppered in.